261 related articles for article (PubMed ID: 23613636)
21. Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis.
He X; Chen Z; Jia M; Zhao X
PLoS One; 2013; 8(7):e70858. PubMed ID: 23923027
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
[TBL] [Abstract][Full Text] [Related]
23. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
[TBL] [Abstract][Full Text] [Related]
24. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
[TBL] [Abstract][Full Text] [Related]
25. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
Yun JA; Kim SH; Hong HK; Yun SH; Kim HC; Chun HK; Cho YB; Lee WY
Oncology; 2014; 86(5-6):318-28. PubMed ID: 24924873
[TBL] [Abstract][Full Text] [Related]
26. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
27. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of Twist and E-cadherin in patients with osteosarcoma.
Yin K; Liao Q; He H; Zhong D
Med Oncol; 2012 Dec; 29(5):3449-55. PubMed ID: 22847601
[TBL] [Abstract][Full Text] [Related]
29. The expressions and prognostic implications of Twist and E-cadherin in adenocarcinomas of the gastroesophageal junction and proximal gastric carcinoma.
Sun S; Gong Q
Medicine (Baltimore); 2019 Dec; 98(52):e18449. PubMed ID: 31876727
[TBL] [Abstract][Full Text] [Related]
30. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
31. TWIST2 inhibits EMT and induces oxidative stress in lung cancer cells by regulating the FGF21-mediated AMPK/mTOR pathway.
Song Y; Zhang W; Zhang J; You Z; Hu T; Shao G; Zhang Z; Xu Z; Yu X
Exp Cell Res; 2021 Aug; 405(1):112661. PubMed ID: 34044016
[TBL] [Abstract][Full Text] [Related]
32. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer.
Larsson A; Fridberg M; Gaber A; Nodin B; Levéen P; Jönsson G; Uhlén M; Birgisson H; Jirström K
BMC Cancer; 2012 Jul; 12():282. PubMed ID: 22769594
[TBL] [Abstract][Full Text] [Related]
33. The indicative function of Twist2 and E-cadherin in HPV oncogene-induced epithelial-mesenchymal transition of cervical cancer cells.
Liu Y; Qian W; Zhang J; Dong Y; Shi C; Liu Z; Wu S
Oncol Rep; 2015 Feb; 33(2):639-50. PubMed ID: 25420506
[TBL] [Abstract][Full Text] [Related]
34. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.
Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D
PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523
[TBL] [Abstract][Full Text] [Related]
35. [Expression and mechanism of Twist2 in glioma].
Wang LZ; Wang WJ; Xiong YF; Xu S; Wang SS; Tu Y; Wang ZY; Yan XL; Mei JH; Wang CL
Zhonghua Bing Li Xue Za Zhi; 2017 Dec; 46(12):832-836. PubMed ID: 29224276
[No Abstract] [Full Text] [Related]
36. Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas.
Viikilä P; Kivelä AJ; Mustonen H; Koskensalo S; Waheed A; Sly WS; Pastorek J; Pastorekova S; Parkkila S; Haglund C
World J Gastroenterol; 2016 Sep; 22(36):8168-77. PubMed ID: 27688658
[TBL] [Abstract][Full Text] [Related]
37. LINC01235-TWIST2 feedback loop facilitates epithelial-mesenchymal transition in gastric cancer by inhibiting THBS2.
Tan YE; Xing Y; Ran BL; Zhang C; Pan SW; An W; Chen QC; Xu HM
Aging (Albany NY); 2020 Nov; 12(24):25060-25075. PubMed ID: 33206629
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinoma.
Zhao CY; Guo ZJ; Dai SM; Zhang Y; Zhou JJ
Tumour Biol; 2013 Oct; 34(5):2983-7. PubMed ID: 23696030
[TBL] [Abstract][Full Text] [Related]
39. Snail promotes lymph node metastasis and Twist enhances tumor deposit formation through epithelial-mesenchymal transition in colorectal cancer.
Fan XJ; Wan XB; Yang ZL; Fu XH; Huang Y; Chen DK; Song SX; Liu Q; Xiao HY; Wang L; Wang JP
Hum Pathol; 2013 Feb; 44(2):173-80. PubMed ID: 22974478
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]